|
1
|
Hernandez RK, Wade SW, Reich A, Pirolli M,
Liede A and Lyman GH: Incidence of bone metastases in patients with
solid tumors: Analysis of oncology electronic medical records in
the United States. BMC Cancer. 18(44)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lutz S, Balboni T, Jones J, Lo S, Petit J,
Rich SE, Wong R and Hahn C: Palliative radiation therapy for bone
metastases: Update of an ASTRO Evidence-Based Guideline. Pract
Radiat Oncol. 7:4–12. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Coleman R, Hadji P, Body JJ, Santini D,
Chow E, Terpos E, Oudard S, Bruland Ø, Flamen P, Kurth A, et al:
Bone health in cancer: ESMO Clinical Practice Guidelines. Ann
Oncol. 31:1650–1663. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rich SE, Chow R, Raman S, Liang Zeng K,
Lutz S, Lam H, Silva MF and Chow E: Update of the systematic review
of palliative radiation therapy fractionation for bone metastases.
Radiother Oncol. 126:547–557. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wegner RE, Matani H, Colonias A, Price F,
Fuhrer R and Abel S: Trends in radiation fractionation for bone
metastases: A contemporary nationwide analysis. Pract Radiat Oncol.
10:402–408. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bedard G, McDonald R, Poon I, Erler D,
Soliman H, Cheung P, Chung H, Chu W, Loblaw A, Chow E and Sahgal A:
Stereotactic body radiation therapy for non-spine bone metastases-a
review of the literature. Ann Palliat Med. 5:58–66. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kowalchuk RO, Waters MR, Richardson KM,
Spencer K, Larner JM, McAllister WH, Sheehan JP and Kersh CR:
Stereotactic body radiation therapy for spinal metastases: A novel
local control stratification by spinal region. J Neurosurg Spine.
34:1–10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
André T, Shiu KK, Kim TW, Jensen BV,
Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs
P, et al: Pembrolizumab in microsatellite-instability-high advanced
colorectal cancer. N Engl J Med. 383:2207–2218. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Antonia SJ, Villegas A, Daniel D, Vicente
D, Murakami S, Hui R, Kurata T, Chiappori A, Li KH, de Wit M, et
al: Overall survival with durvalumab after chemoradiotherapy in
stage III NSCLC. N Engl J Med. 379:2342–2350. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Makita K, Hamamoto Y, Kanzaki H, Kataoka
M, Yamamoto S, Nagasaki K, Ishikawa H, Takata N, Tsuruoka S, Uwatsu
K and Kido T: Local control of bone metastases treated with
external beam radiotherapy in recent years: A multicenter
retrospective study. Radiat Oncol. 16(225)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gerszten PC, Mendel E and Yamada Y:
Radiotherapy and radiosurgery for metastatic spine disease: What
are the options, indications, and outcomes? Spine (Phila Pa 1976).
34 (Suppl 22):S78–S92. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
van der Linden YM, Steenland E, van
Houwelingen HC, Post WJ, Oei B, Marijnen CA and Leer JW: Dutch Bone
Metastasis Study Group. Patients with a favorable prognosis are
equally palliated with single and multiple fraction radiotherapy:
Results on survival in the Dutch bone metastasis study. Radiother
Oncol. 78:245–253. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Palma DA, Olson R, Harrow S, Gaede S,
Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP,
et al: Stereotactic ablative radiotherapy versus standard of care
palliative treatment in patients with oligometastatic cancers
(SABR-COMET): A randomised, phase 2, open-label trial. Lancet.
393:2051–2058. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ito K, Ogawa H, Shimizuguchi T, Nihei K,
Furuya T, Tanaka H and Karasawa K: Stereotactic body radiotherapy
for spinal metastases: Clinical experience in 134 cases from a
single Japanese institution. Technol Cancer Res Treat.
17(1533033818806472)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ito K, Yamaguchi T, Ogawa H, Nakajima Y
and Karasawa K: Stereotactic body radiotherapy for bone metastases
in patients with colorectal cancer. Jpn J Clin Oncol. 50:1442–1446.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
McGee HM, Carpenter TJ, Ozbek U, Kirkwood
KA, Tseng TC, Blacksburg S, Germano IM, Green S and Buckstein M:
Analysis of local control and pain control after spine stereotactic
radiosurgery reveals inferior outcomes for hepatocellular carcinoma
compared with other radioresistant histologies. Pract Radiat Oncol.
9:89–97. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jung IH, Yoon SM, Kwak J, Park JH, Song
SY, Lee SW, Ahn SD, Choi EK and Kim JH: High-dose radiotherapy is
associated with better local control of bone metastasis from
hepatocellular carcinoma. Oncotarget. 8:15182–15192.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Smith BW, Joseph JR, Saadeh YS, La Marca
F, Szerlip NJ, Schermerhorn TC, Spratt DE, Younge KC and Park P:
Radiosurgery for treatment of renal cell metastases to spine: A
systematic review of the literature. World Neurosurg. 109:e502–9.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Leeman JE, Bilsky M, Laufer I, Folkert MR,
Taunk NK, Osborne JR, Arevalo-Parez J, Zatcky J, Alektiar KM,
Yamada Y, et al: Stereotactic body radiotherapy for metastatic
spinal sarcoma: A detailed patterns-of-failure study. J Neurosurg
Spine. 25:52–58. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Stinauer MA, Kavanagh BD, Schefter TE,
Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M and
Raben D: Stereotactic body radiation therapy for melanoma and renal
cell carcinoma: Impact of single fraction equivalent dose on local
control. Radiat Oncol. 6(34)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Batson OV: The vertebral vein system as
mechanism for spread of metastases. Am J Roentgenol Radium Ther
Nucl Med. 48:715–718. 1942.https://pubmed.ncbi.nlm.nih.gov/13444513/.
|
|
22
|
Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE,
Dilling TJ, Eschrich SA, Sridhar R and Torres-Roca JF: Differences
between colon cancer primaries and metastases using a molecular
assay for tumor radiation sensitivity suggest implications for
potential oligometastatic SBRT patient selection. Int J Radiat
Oncol Biol Phys. 92:837–842. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Morony S, Capparelli C, Sarosi I, Lacey
DL, Dunstan CR and Kostenuik PJ: Osteoprotegerin inhibits
osteolysis and decreases skeletal tumor burden in syngeneic and
nude mouse models of experimental bone metastasis. Cancer Res.
61:4432–4436. 2001.PubMed/NCBI
|
|
24
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tokuhashi Y, Matsuzaki H, Toriyama S,
Kawano H and Ohsaka S: Scoring system for the preoperative
evaluation of metastatic spine tumor prognosis. Spine (Phila Pa
1976). 15:1110–1113. 1990.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tokuhashi Y, Matsuzaki H, Oda H, Oshima M
and Ryu J: A revised scoring system for preoperative evaluation of
metastatic spine tumor prognosis. Spine (Phila Pa 1976).
30:2186–2191. 2005.PubMed/NCBI View Article : Google Scholar
|
